BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hassan Z, Bosch OG, Singh D, Narayanan S, Kasinather BV, Seifritz E, Kornhuber J, Quednow BB, Müller CP. Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs. Front Psychiatry 2017;8:152. [PMID: 28868040 DOI: 10.3389/fpsyt.2017.00152] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Dolgova OB, Grekhov IA. [Method for determination the action of psychoactive agents on the central nervous system based on the molecular docking method]. Sud Med Ekspert 2021;64:47-52. [PMID: 34264581 DOI: 10.17116/sudmed20216404147] [Reference Citation Analysis]
2 Robins MT, Blaine AT, Ha JE, Brewster AL, van Rijn RM. Repeated Use of the Psychoactive Substance Ethylphenidate Impacts Neurochemistry and Reward Learning in Adolescent Male and Female Mice. Front Neurosci 2019;13:124. [PMID: 30837836 DOI: 10.3389/fnins.2019.00124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Yue K, Kopajtic TA, Katz JL. Abuse liability of mitragynine assessed with a self-administration procedure in rats. Psychopharmacology 2018;235:2823-9. [DOI: 10.1007/s00213-018-4974-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 9.3] [Reference Citation Analysis]
4 Ruiz P, Calliari A, Pautassi RM. Reserpine-induced depression is associated in female, but not in male, adolescent rats with heightened, fluoxetine-sensitive, ethanol consumption. Behavioural Brain Research 2018;348:160-70. [DOI: 10.1016/j.bbr.2018.04.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
5 Michienzi AE, Borek HA. Emerging Agents of Substance Use/Misuse. Emergency Medicine Clinics of North America 2022. [DOI: 10.1016/j.emc.2022.01.001] [Reference Citation Analysis]
6 Yusoff NH, Mansor SM, Müller CP, Hassan Z. Baclofen blocks the acquisition and expression of mitragynine-induced conditioned place preference in rats. Behavioural Brain Research 2018;345:65-71. [DOI: 10.1016/j.bbr.2018.02.039] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
7 Kalinichenko LS, Gulbins E, Kornhuber J, Müller CP. The role of sphingolipids in psychoactive drug use and addiction. J Neural Transm 2018;125:651-72. [DOI: 10.1007/s00702-018-1840-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
8 Jurek L, Nourredine M, Megarbane B, d'Amato T, Dorey JM, Rolland B. [The serotonin syndrome: An updated literature review]. Rev Med Interne 2019;40:98-104. [PMID: 30243558 DOI: 10.1016/j.revmed.2018.08.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
9 Ahmed SH, Badiani A, Miczek KA, Müller CP. Non-pharmacological factors that determine drug use and addiction. Neurosci Biobehav Rev 2020;110:3-27. [PMID: 30179633 DOI: 10.1016/j.neubiorev.2018.08.015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
10 Yusoff NHM, Hassan Z, Murugaiyah V, Müller CP. The effect of mitragynine on extracellular activity of brain dopamine and its metabolites. Brain Res Bull 2021;178:1-8. [PMID: 34774992 DOI: 10.1016/j.brainresbull.2021.11.002] [Reference Citation Analysis]
11 Müller CP. Drug instrumentalization. Behav Brain Res 2020;390:112672. [PMID: 32442549 DOI: 10.1016/j.bbr.2020.112672] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
12 Hassan R, Othman N, Mansor SM, Müller CP, Hassan Z. Proteomic analysis reveals brain Rab35 as a potential biomarker of mitragynine withdrawal in rats. Brain Res Bull 2021;172:139-50. [PMID: 33901587 DOI: 10.1016/j.brainresbull.2021.04.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Vijeepallam K, Pandy V, Murugan DD, Naidu M. Methanolic extract of Mitragyna speciosa Korth leaf inhibits ethanol seeking behaviour in mice: involvement of antidopaminergic mechanism. Metab Brain Dis 2019;34:1713-22. [PMID: 31396844 DOI: 10.1007/s11011-019-00477-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
14 Sushma, Divakar A, Kanchan S, Jha G, Mishra S, Sharma D, Rath SK. Alcohol induced impairment/abnormalities in brain: Role of MicroRNAs. Neurotoxicology 2021;87:11-23. [PMID: 34478768 DOI: 10.1016/j.neuro.2021.08.013] [Reference Citation Analysis]
15 Lowe H, Toyang N, Steele B, Valentine H, Grant J, Ali A, Ngwa W, Gordon L. The Therapeutic Potential of Psilocybin. Molecules 2021;26:2948. [PMID: 34063505 DOI: 10.3390/molecules26102948] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Japarin RA, Yusoff NH, Hassan Z, Müller CP, Harun N. Cross-reinstatement of mitragynine and morphine place preference in rats. Behav Brain Res 2021;399:113021. [PMID: 33227244 DOI: 10.1016/j.bbr.2020.113021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Gonçalves J, Luís Â, Gallardo E, Duarte AP. Psychoactive Substances of Natural Origin: Toxicological Aspects, Therapeutic Properties and Analysis in Biological Samples. Molecules 2021;26:1397. [PMID: 33807728 DOI: 10.3390/molecules26051397] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Nichols KA, Paciullo CA. Subdissociative Ketamine Use in the Emergency Department. Adv Emerg Nurs J 2019;41:15-22. [PMID: 30702529 DOI: 10.1097/TME.0000000000000222] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 You CY, Hassan Z, Müller CP, Suhaimi FW. Mitragynine improves cognitive performance in morphine-withdrawn rats. Psychopharmacology (Berl) 2021. [PMID: 34693456 DOI: 10.1007/s00213-021-05996-4] [Reference Citation Analysis]
20 Suhaimi FW, Hassan Z, Mansor SM, Müller CP. The effects of chronic mitragynine (Kratom) exposure on the EEG in rats. Neurosci Lett 2021;745:135632. [PMID: 33444671 DOI: 10.1016/j.neulet.2021.135632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Müller E, Hillemacher T, Müller CP. Kratom instrumentalization for severe pain self-treatment resulting in addiction - A case report of acute and chronic subjective effects. Heliyon 2020;6:e04507. [PMID: 32715144 DOI: 10.1016/j.heliyon.2020.e04507] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
22 Savulich G, Bowden-Jones O, Stephenson R, Brühl AB, Ersche KD, Robbins TW, Sahakian BJ. "Hot" and "Cold" Cognition in Users of Club Drugs/Novel Psychoactive Substances. Front Psychiatry 2021;12:660575. [PMID: 33841219 DOI: 10.3389/fpsyt.2021.660575] [Reference Citation Analysis]
23 Müller E, Hillemacher T, Müller CP. Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic - A case report. Heliyon 2021;7:e07039. [PMID: 34136676 DOI: 10.1016/j.heliyon.2021.e07039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Scotton WJ, Hill LJ, Williams AC, Barnes NM. Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions. Int J Tryptophan Res 2019;12:1178646919873925. [PMID: 31523132 DOI: 10.1177/1178646919873925] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
25 Arillotta D, Schifano F, Napoletano F, Zangani C, Gilgar L, Guirguis A, Corkery JM, Aguglia E, Vento A. Novel Opioids: Systematic Web Crawling Within the e-Psychonauts' Scenario. Front Neurosci 2020;14:149. [PMID: 32256304 DOI: 10.3389/fnins.2020.00149] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
26 Tay YL, Amanah A, Adenan MI, Wahab HA, Tan ML. Mitragynine, an euphoric compound inhibits hERG1a/1b channel current and upregulates the complexation of hERG1a-Hsp90 in HEK293-hERG1a/1b cells. Sci Rep 2019;9:19757. [PMID: 31874991 DOI: 10.1038/s41598-019-56106-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]